See also this year's filing and all EDGAR filings for this company.
PDF Report 0001597553_2023_Sage_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001597553, Sage Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,336,980,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,898,000 |
| 3 | remainder_Assets | 16,571,000 |
| 4 | LiabilitiesCurrent | 99,259,000 |
| 5 | LiabilitiesNoncurrent | 4,591,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 227,699,000 |
| 9 | ResearchAndDevelopmentExpense | 326,163,000 |
| 10 | remainder_Expenses | 813,000 |
| 11 | remainder_Revenues | 7,686,000 |
| 12 | remainder_NetIncome | 14,205,000 |
| 13 | remainder_ComprehensiveNetIncome | -7,546,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,356,449,000 |
| 1 | Liabilities | 103,850,000 |
| 2 | Expenses | 554,675,000 |
| 3 | Revenues | 7,686,000 |
| 4 | StockholdersEquity | 1,252,599,000 |
| 5 | NetIncome | -532,784,000 |
| 6 | ComprehensiveNetIncome | -536,557,000 |
| 7 | BaseVar | 1,022,205,500 |
| 8 | EconomicCapitalRatio | 2.22 |
Edgar->Model Mapping
Feature Distribution
Change over Time
